AFT Pharma’s Global Growth Engine | Auckland News

AFT Pharmaceuticals is on a high-growth trajectory with eight patented drugs and 24 off-patent injectables in the pipeline, targeting billion-dollar markets. Backed by a proven track record of 17% annual growth and self-sustaining R&D funded by current product sales, the company is accelerating clinical trials to bring new medicines to market faster. With a strong focus on the complex U.S. market and active operations in 87 countries—including the UK, Canada, and Asia—they’re expanding global reach through strategic licensing deals and market hubs. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ca342086a55b385d